ACUTE INFECTIOUS DIARRHEA
Definition
Diarrhea: more than 3 unformed stools/24 h or
increased stool volumen >300 g/24 h
Diarrhea
• Acute (several hours or days), chronic (several days
or months)
• Osmotic, secretory, motility-related, mixed
• Infective, non-infective
The importance of acute diarrheal diseases
• The second most common diseases worldwide (after
acute respiratory infections)
• Leading cause of morbidity and major cause of
mortality in children living in nondeveloped countries
Bacteria
• Salmonella spp.
• Shigella spp.
• Campylobacter spp.
• Yersinia enterocolitica
• E.coli
• V. Cholerae
• Clostridium (difficile, perfringens)
Viruses
• Rotavirus
• Norwalk (Norovirus)
• Adenovirus
• Calicivirus
• Astrovirus
• Coronavirus
• CMV
Parasites
• Entamoeba hystolitica
• Giardia (Lamblia) intestinalis
• Isospora belli
• Cryptosporidium parvum
• Cyclospora cayetanensis
Diarrhea
Epidemiology
Host Virulence
defenses factors
Epidemiology
• Age
(children<5 years of age, older adults)
• Cultural and personal habits
(food preparation, personal hygiene…)
• Location
(day-care centers, chronic-care institutions, hospitals-
C.difficile)
• Traveler`s history- 20-50% of people who travel to
tropical regions experience diarrhea
Host defenses
• Normal bowel flora
• Gastric acid
• Intestinal motility
• Immunity
Normal bowel flora
• Bacteria that normally inhabit the intestine act as an
important host defense by preventing colonization of
potential enteric pathogens
• More than 600 species
(99% are anaerobic bacteria)
Gastric acid
• The risk for enteric infections is increased in
patients who have undergone gastric surgery and
those treated with antacids or H-2 blockers
• Salmonella, Shigella, Giardia and helmintic infections
are common among those patients
• Rotavirus is highly stable to acid
Intestinal motility
• Normal peristalsis is the major mechanism for
clearance of bacteria from the intestines
• When intestinal motility is impared, the frequency of
bacterial overgrowth and infection with enteric
pathogens is much increased
• Patients treated with antimotility agents experience
prolonged fever and shedding of organisms and higher
frequency of bacteremia
Immunity
• The wide spectrum of viral, bacterial, fungal and
parasitic infections in patients with AIDS highlights
the importance of cellular immunity in protecting
normal host from these pathogens
Immunity
• Humoral immunity consists of systemic IgG and IgM
as well as secretory IgA
• Binding of bacterial antigens to the M cells and their
presentation to subepithelial lymphoid tissue lead to
the proliferation of lymphocytes which populate
mucosal tissues as IgA-secreting plasma cells
Virulence factors
Enteric pathogens have developed a variety of tactics to
overcome host defenses
• Inoculum size
• Adherence
• Toxin production
• Invasion
Inoculum size
• In case of Shigella, enterohemorrhagic E. coli, Giardia
and Entamoeba as few as 10-100 bacteria or cysts can
produce infection
• About 1 million Vibrio cholerae organisms must be
ingested to cause disease
Adherence
• The initial step in the pathogenic process is the
adherence to the gastrointestinal mucosa
• Organisms colonize the mucosa and compete with the
normal bowel flora which is an important advantage in
causing disease
Toxin production
• Enterotoxins cause watery diarrhea by acting directly
on secretory mechanisms
• Cytotoxins cause destruction of mucosal cells and
associated inflammatory diarrhea
• Neurotoxins act directly on the central or peripheral
nervous system
• Some toxins act by more than one mechanism
Cholera toxin
A subunit catalyzes the ADP
ribosylation of a GTP-binding
protein
Persistent activation of
adenylate cyclase
Increase of cyclic AMP
Increased Cl- secretion and
decreased Na+ absorption
Loss of fluid and diarrhea
A subunit contains the enzymatic activity
B subunit pentamer binds toxin to the enterocyte
surface receptor
Other toxins
• Enterotoxigenic E.coli produces heat-labile
enterotoxin (LT) which is similar to cholera toxin and
heat-stable enterotoxin (ST) which acts by elevation
of cyclic GMP
Other toxins
• Cytotoxins destroy intestinal mucosal cells and
produce the syndrome of dysentery (Shigella,
Clostridium, E.coli)
• Neurotoxins are produced outside the host and cause
the symptoms soon after ingestion (Staph. aureus,
Bacillus cereus, Clostridium botulinum)
Invasion
• Invasion and inflammation of the mucosa with
destruction of epithelial cells (Shigella, EIEC)
• Invasion and inflammation without destruction of
enterocytes (Salmonella)
• Penetration of the intact intestinal mucosa,
multiplication in Peyer`s patches and intestinal lymph
nodes, dissemination through the bloodstream to
cause enteric fever (S. typhi, Y.enterocolitica)
Fecal leukocytes
• White blood cells in a
stool sample stained
with Methylene blue
Types of enteric infections
Type of Non- Inflammatory Penetrating
infection inflammatory
Mechanisms Toxin production Invasion Invasion/
penetration
Location Proximal small Colon Distal small
bowel bowel
Fever No Fever Fever
Abdominal pain No Abdominal Minimal
cramping, tenesmus abdominal pain
Illnes Watery diarrhea Dysentery (blood, Enteric fever
mucus)
Fecal No PMN Mononuclear
leukocytes
Microorganism V.cholerae, E.coli, Shigella, E.coli, S. typhi,
S. aureus, Campylobacter, paratyphi A,B,C
Rotavirus,Giardia C.difficile, Yersinia
Cryptosporidium Salmonella,
E.hystolitica
Approach to the patient
• History : clinical presentation
• Physical examination: signs of dehydration (dry
mouth, thirst, decreased urine output, hypotension,
tachycardia, confusion, shock), careful abdominal
examination to exclude surgical conditions
• Diagnostic approach: distinction between
inflammatory and noninflammatory disease
Laboratory analyses
• Blood count
• Biochemical analysis (azotemia, loss of electrolytes,
acidosis)
• Inflammatory parameters (CRP, fibrinogen)
• Malabsorption (protein, albumin,Fe)
Diagnosis
• Stool culture (selective growth medium)
• Fresh stool examination for parasites
• Rapid ELISA stool tests for C.diff. toxin A and B
• Stool test for detection of Shiga- toxin
• ELISA stool tests (Rotavirus)
• PCR
• Serologic blood testing (E.hystolitica)
• Blood culture (S.typhi)
Treatment
• Rehydration
Mild diarrhea- oral rehydration
Severe diarrhea- intravenous rehydration
• Antimicrobial drugs- dysentery, serious inflammatory
diarrhea with high fever, bacteremia, complications
• Probiotics-live microorganisms that act as inhibitors
of pathogens in the intestine
BACTERIAL FOOD POISONING
Staphylococcus aureus
• Source: infected human carriers (nose, mouth, skin)
• Food contamination (ham, polutry, mayonnaise, ice
cream)
• Bacteria multiplies and produces heat-stable
Staphylococcal enterotoxin B
• Pathogenesis: symptoms are mediated through the
autonomous nervous system
Staphylococcus aureus
Clinical presentation
• Short incubation period (1-6 hours)
• Nausea, vomiting, diarrhea, abdominal cramps
• No fever
• Illness lasts less than 24 hours
Staphylococcus aureus
Diagnosis
• Diagnosis is generally based only on the signs and
symptoms of the disease
• Staph.aureus can be identified in stool or vomit, and
bacteria and toxin can be detected in food
• Testing is usually reserved for outbreaks involving
several people
• Therapy: adequate rehydration
Bacillus cereus
• A Gram-positive facultatively aerobic sporeformer
• The vomiting (emetic) form of illness is caused by a
low molecular weight, heat-stable peptide (similar to
staphylococcal enterotoxin B)
• The diarrheal form of illness is caused by a large
molecular weight protein (similar to E.coli type of
enterotoxin)
Bacillus cereus
Emetic form
• Source: rice (heat –resistant spores, heat-stable
toxin)
• Incubation period 1-6 hours
• Clinical presentation: the same as in Staphylococcal
food poisoning
Bacillus cereus
Diarrheal form
• Sources: meat, vegetables, beans, cereals
• Incubation period 8-16 hours
• Clinical presentation: diarrhea, abdominal cramps,
vomiting and fever uncommon
• Illness is self-limited rarely lasting for more than 24
hours
Bacillus cereus
• Diagnosis: isolation of a B. cereus serotype known to
cause foodborne illness from the suspect food or
from the feces or vomitus of the patient
• Therapy: nonspecific- rehydration
Clostridium perfringens
• A Gram-positive anaerobic, spore forming bacteria
• Sources: beef, poultry, legumes
• Clostridium perfringens enterotoxin (CPE) is produced
in intestinal tract
Clostridium perfringens
• Incubation period 8-14 hours
• Clinical presentation: diarrhea, abdominal cramps,
rarely vomiting
• Diagnosis: testing contaminated food or stool for
Clostridium perfringens and detection of enterotoxin
in contaminated food and feces
• Therapy: adequate rehydration
Vibrio parahemolyticus
• Source: raw seafood, in the summer months
• Incubation period 12-24 h
• Clinical presentation: abdominal cramps and diarrhea,
rarely dysentery-like illness with bloody or mucoid
stools
• Treatment: adequate rehydration, in serious cases
antibiotics
VIRAL GASTROENTERITIS
Gastrointestinal viruses
Virus type Genome Risk groups Seasonality Diagnosis Therapy
structure
Rotavirus RNA Children<3 Winter ELISA Oral rehydration
years
Adenovirus DNA Children<3 Year-round ELISA Oral rehydration
years
Calicivirus RNA Children - EM Oral rehydration
Astrovirus RNA Children, Winter EM Oral rehydration
immunocomp
romised pt.
Norwalk-like RNA Children, Winter EM Oral rehydration
adults
Parvovirus DNA - Year-round EM None
Picornavirus RNA - - Culture,EM None
Coronavirus RNA - - EM None
Rotavirus
• RNA virus, member of
the Reoviridae family
• EM picture of mutiple
rotavirus particles
Epidemiology
• Most important cause of severe diarrhea in infants
and children<3 years old
• Mild diarrhea in adults: family members of affected
infants, geriatric patients and immunocompromised
hosts
• 10% of cases of traveler‘s diarrhea
• Infection is seasonal, occuring in the cooler winter
months
Pathogenesis
• Virus is spread by the fecal-oral route
• Virus infects and kills epithelial mature villus cells of
the small intestine
• Lack of absorption of carbohydrates and other
nutrients results in osmotic diarrhea
Clinical presentation
• Vomiting, diarrhea (rarely with mucus)
• Fever >390C (one third of the patients)
• In older patients infection is mostly subclinical
Diagnosis
• ELISA – detection of rotavirus antigen in fecal
specimens
• PCR (only for research purposes)
Treatment
• Standard oral rehydration therapy
• Intravenous rehydration in serious cases
• Multivalent rotavirus vaccine (for children under the
age of 6 months)
Norwalk-like virus (Norovirus)
• Epidemics of non-bacterial gastroenteritis
• Waterborne epidemics in nursing home, cruise ship,
camps
• Traveler‘s diarrhea
• Infection is common year-round with a clear winter
peak
Pathogenesis
• Virus infects epithelial cells of the small intestine
• Carbohydrate malabsorption, mild steatorrhea,
decreased levels of brush border enzymes
Clinical presentation
• Incubation period 18-72 hours
• Nausea, abdominal cramps, vomiting, diarrhea
• Fever, headache, myalgias are common
• The illness is mild and self-limited
Diagnosis and treatment
• ELISA and PCR- based assays
• Oral and intravenous rehydration
DYSENTERY
Definition
• Acute infectious inflammatory colitis which is
characterized by frequent passage of small-volume
stools consisting of blood and mucus
Dysentery
• Differential diagnosis:
Shigella, enterohemorrhagic E.coli (EHEC),
enteroinvasive E. coli (EIEC), Campylobacter jejuni,
Salmonella enteritidis, Clostridium difficile,
Entamoeba histolytica, Cytomegalovirus,
noninfectious conditions (ulcerative colitis)
Shigellosis
• Gram-negative nonmotile bacilli, members of the
family Enterobacteriaceae
• Four species:
S. dysenteriae
S. flexneri
S. sonnei
S. boydii
Epidemiology
• 140 million cases and almost 600,000 deaths among
children under age of 5 years in developing countries
• Natural pathogen for humans
Epidemiology
• Fecal-oral route of transmission
Direct contact (day-care centers, centers for
retarded children, household transmission or by anal-
oral sexual practices among gay men)
Indirect infection(food, water, flies-pools, lakes,
cruise ships, military personnel)
Pathogenesis
• Infective dose 10-100 bacteria
• Oral ingestion, passing the gastric acid barrier
• Attachment to colonic cells, entry by an endocytic
mechanism, movement to the cell membrane, cell-to-
cell spread of infection
• Intracellular multiplication causes cell damage and
death resulting in mucosal ulcerations
Pathogenesis
Pathogenesis
Virulence factors
• 120-140 MDa plasmid responsible for invasion and
spreading of bacteria among colonic cells (also
present in EIEC)
• Shigella enterotoxins ShET-1 and-2 alter electrolyte
transport and cause fluid secretion, and they also act
as cytotoxins by destroying epithelial cells
Pathogenesis
Virulence factors
• Shiga-toxin – enterotoxin produced by S.dysenteriae
type 1, also plays a role in microangiopathic
complications (also present in EHEC)
Clinical presentation
• Incubation period 24-48 hours
• 25% of patients have no symptoms
• 25% have mild fever
• 25% have fever and self-limited watery diarrhea
• 25% have fever and watery diarrhea that progress to
bloody diarrhea (dysentery)
Bloody diarrhea with mucus
Clinical presentation
• Abdominal cramps
• Tenesmus- the painful straining with stooling that
may lead to rectal prolapse
• Bacteremia in young children and AIDS
• Complications- toxic megacolon and perforation
• Prolonged carriage of Shigella in AIDS
Extraintestinal manifestations
• Hemolytic-uremic syndrome (HUS)
Anemia with congestive heart failure
Anuria with renal failure
Leukemoid reaction
Thrombocytopenia
Encephalopathy
• Seizures in young children with high fever
• Reiter`s syndrome- reactive arthritis
Diagnosis
• Stool culture (Mac Conkey agar,Salmonella-Shigella
agar, Hektoen enteric or xylose-lysine-dexycholate)
• PCR
• Enzyme immunoassay for detection of Shiga-toxin in
the stool
Salmonella-Shigella (SS) agar
• Typical uncoloured
colonies of Shigella
(flexneri)
Shigellosis: Endoscopy
• Endoscopy- mucosa is
hemorrhagic with
mucous discharge, focal
ulcerations and exudate
in distal colon
Diagnosis
• Positive fecal leukocytes
• Leukocytosis
• Anemia due to blood loss
• Prerenal azotemia and acidosis (dehydration)
Treatment
• Mild diarrhea- oral rehydration
• Dysentery- rehydration (oral, intravenous) and
antibiotics
• Many shigellae are resistant to ampicillin and
trimethoprim-sulfamethoxazole
• Drugs of choice- 4-fluoroquinolones (ciprofloxacin),
azithromycin, ceftriaxone
Treatment
• Toxic megacolon- colectomy
• Haemolytic-uremic syndrome (HUS)- dialysis
• Prevention- adequate environmental and personal
hygiene
Entamoeba hystolitica
• Fecal-oral infection (contaminated water and food,
anal-oral transmission among homosexuals)
• Cysts are infective, and trophozoites are responsible
for invasion and inflammation of the mucosa
Presentation
• Mild diarrhea
• Dysentery
• Chronic diarrhea with weight loss
• Extraintestinal disease –liver abscess
Therapy
Invazive amebiasis and abscess
• Metronidazole 3x750 mg PO 10 days
• Metronidazole 3-4x500 mg IV 10 days
Eradication of cysts
• Paromomycine 3x500 mg PO 10 days
Campylobacteriosis
• Motile curved gram-negative rods
• Campylobacters are found in the gastrointestinal
tract of many animals and household pets
• Human is infected by using raw and undercooked
food products (poultry, milk) or through direct
contact with animals
Clinical presentation
• Incubation period 1-7 days
• Fever, headache, myalgia (first 12-48h)
• Abdominal pain (cramping)
• Diarrhea varies from severeal watery stools to bloody
stools
Clinical presentation
Complications:
• Bacteremia in patients with AIDS and
hypogammaglobulinemia
• Cholecystitis, pancreatitis, endocarditis, reactive
arthritis
• Guillain-Barré syndrome (Campylobacter triggers 20-
40% of all cases)
Diagnosis
• Stool culture in Campylobacter-specific media
• Blood culture
• Direct microscopic examination of stool: organisms
with vibroid morphology
Treatment
• Fluid and electrolyte replacement
• In case of high fever and bloody diarrhea persisting
for more than 1 week antibiotics are indicated:
erythromycin, clarithromycin, azithromycin,
ciprofloxsacin
• For systemic infections: gentamycin, imipenem,
ciprofloxsacin
E.Coli
Pathotypea Epidemiology Clinical Defining Molecular Responsible
Intestinal Pathogenic
Syndrome b
E. coli
Trait Genetic Elementc
EHEC Food, water, Hemorrhagic colitis, Shiga toxin Lambda-like Stx1-
person-to-person; hemolytic-uremic or Stx2-encoding
all ages, syndrome bacteriophage
industrialized
countries
ETEC Food, water; young Traveler's diarrhea Heat-stable and - Virulence plasmid(s)
children in and labile enterotoxins,
travelers to colonization factors
developing
countries
EPEC Person-to-person; Watery diarrhea Localized EPEC adherence
young children and adherence, factor plasmid
neonates in attaching and pathogenicity island
developing effacing lesion on (locus for
countries intestinal epithelium enterocyte
effacement)
EIEC Food, water; Dysentery Invasion of colonic Multiple genes
children in and epithelial cells, contained primarily
travelers to intracellular in large virulence
developing multiplication, cell- plasmid
countries to-cell spread
EAEC ? Food, water; Traveler's diarrhea, Aggregative/diffuse Chromosomal or
children in and acute diarrhea, adherence, plasmid-associated
travelers to persistent diarrhea virulence factors adherence and
developing regulated by AggR toxin genes
countries; all ages,
industrialized
countries
Traveler`s diarrhea
• Ingestion of contaminated food and water
• Illness begins within first 3-5 days
• Abdominal cramps and watery diarrhea
• Disease is self-limited lasting for 1-5 days
• Causes: enterotoxigenic E.coli, Shigella, Salmonella,
Campylobacter, Vibrio spp., Giardia, Entamoeba
hystolitica, Cryptosporidium, Cyclospora, Rotavirus
EHEC O157:H7
• Fecal-oral transmission mostly through the
contaminated water and food
• Source: digestive tract of the cattle and wild animals
(deer, swine)
Pathogenesis and clinical presentation
• Bacteria is invasive and produces Shiga-like toxin
• Incubation period 3-4 days
• Abdominal cramps, diarrhea, blood and mucus in stool
• HUS (10%), mortality 3-5 %
Therapy
• Symptomatic
• The use of antibiotics is contradictory
• Dialysis